Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
Abstract
We investigated the diagnostic and prognostic potential of serum N -glycan profiling for castration-resistant prostate cancer (CRPC). We retrospectively investigated serum N -glycan structural analysis by glycoblotting for 287 patients with benign prostatic hyperplasia (BPH), 289 patients with newly diagnosed prostate cancer (PC), 57 patients with PC treated with androgen-deprivation therapy without disease progression (PC-ADT), and 60 patients...
Paper Details
Title
Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
Published Date
Nov 14, 2019
Journal
Volume
9
Issue
1
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History